Bisphosphonate-associated osteonecrosis

Known as: BON, Bisphosphonate Osteonecrosis, Bisphosphonate Associated Osteonecrosis 
Necrosis of the mandible or maxilla in patients receiving intravenous or oral bisphosphonate therapy. It usually manifests with slow healing or… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
PURPOSE To report a case series of patients with the nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw-a… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND In addition to other treatments, patients with prostate cancer (pCA) and bone metastasis receive bisphosphonates… (More)
  • table 1
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CONTEXT Bisphosphonate-related osteonecrosis (BON) of the jaws is a newly identified condition for which the exact mechanism… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Actinomycosis of the jaws is a rare disease, which has been recently described in patients with infected osteoradionecrosis (IORN… (More)
  • table 1
  • figure 1
  • figure 4
  • figure 2
  • figure 3
Is this relevant?
Review
2006
Review
2006
We present current knowledge of bisphosphonate-associated osteonecrosis, a new oral complication in oncology. It was first… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
This article describes a 2-systems model that explains social behavior as a joint function of reflective and impulsive processes… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
This paper presents a comprehensive study of contention-resolution schemes in a multi-wavelength optical packet-switched network… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
In the context of additional characterization of the pathoetiologic associations of heritable hypofibrinolysis and thrombophilia… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE Risedronate, a new pyridinyl bisphosphonate, is a potent antiresorptive bone agent. This study examines the safety and… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND Bisphosphonates are effective against the increased bone resorption caused by certain diseases because they inhibit… (More)
Is this relevant?